+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ulcerative Colitis Global Clinical Trials Review, H2, 2019

  • ID: 4629786
  • Clinical Trials
  • December 2019
  • Region: Global
  • 876 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AbbVie Inc
  • Bristol-Myers Squibb Co
  • Ferring Holding SA
  • ICON Plc
  • IQVIA Holdings Inc
  • Johnson & Johnson
  • MORE
Ulcerative Colitis Global Clinical Trials Review, H2, 2019

Summary

The clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2019“ provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcerative Colitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie Inc
  • Bristol-Myers Squibb Co
  • Ferring Holding SA
  • ICON Plc
  • IQVIA Holdings Inc
  • Johnson & Johnson
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Ulcerative Colitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Ulcerative Colitis
  • Nov 22, 2019: Abivax to expand Phase IIb ulcerative colitis trial to France
  • Oct 22, 2019: Janssen reports two-year UNIFI data for Stelara in ulcerative colitis
  • Oct 22, 2019: Arena Pharmaceuticals presented new data analyses demonstrating the long-term safety and efficacy of once-daily Etrasimod in patients with moderately to severely active Ulcerative Colitis at UEG Week
  • Oct 21, 2019: Retrospective real-world comparative analysis highlights safety of vedolizumab and Anti-TNFa therapies in biologic-naïve patients with Ulcerative Colitis or Crohn’s Disease
  • Oct 21, 2019: ABIVAX reports impressive 12-month efficacy and safety data from ABX464 Ulcerative Colitis Maintenance Study at United European Gastroenterology Conference
  • Oct 21, 2019: Biogen and Samsung Bioepis to present data for Adalimumab biosimilar at United European Gastroenterology Week
  • Oct 18, 2019: Arena Pharmaceuticals presents data on etrasimod at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community
  • Clinical Trial Profile Snapshots
Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About the Author
  • Contact Us
  • Source
List of Tables
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region, 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019*
  • Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2019*
  • Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2019*
  • Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
List of Figures
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019*
  • Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2019*
  • Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2019*
  • Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
  • Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • Methodology
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Takeda Pharmaceutical Co Ltd
  • Pfizer Inc
  • AbbVie Inc
  • Johnson & Johnson
  • Bristol-Myers Squibb Co
  • Ferring Holding SA
  • IQVIA Holdings Inc
  • Bausch Health Companies Inc
  • Merck & Co Inc
  • ICON Plc
Note: Product cover images may vary from those shown
Adroll
adroll